Roberta Caputo Martina Pagliuca Matilde Pensabene Sara Parola Michelino De Laurentiis
10.3389/fonc.2023.1214660
Front Oncol
2023 Aug 4;13:1214660.
brca mutation parp inhibitor advanced breast cancer immunotherapy triple negative breast cancer
CC BY
https://pubmed.ncbi.nlm.nih.gov/37601649/
Case Reports
PMC10438988
37601649
Long-term complete response with third-line PARP inhibitor after immunotherapy in a patient with triple-negative breast cancer: a case report
2023